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Phenotypic spectrum associated with de novo and
inherited deletions and duplications at 16p11.2 in
individuals ascertained for diagnosis of autism
spectrum disorder
Bridget A Fernandez,1,3 Wendy Roberts,5 Brian Chung,6 Rosanna Weksberg,6
Stephen Meyn,6 Peter Szatmari,7 Ann M Joseph-George,8,10 Sara MacKay,3
Kathy Whitten,3 Barbara Noble,3 Cathy Vardy,2,4 Victoria Crosbie,4 Sandra Luscombe,4
Eva Tucker,4 Lesley Turner,1,3 Christian R Marshall,8 Stephen W Scherer8,9
ABSTRACT
Background Recurrent microdeletions and
microduplications of w555 kb at 16p11.2 confer
susceptibility to autism spectrum disorder (ASD) in up to
1% of ASD patients. No physical or behavioural features
have been identified that distinguish these individuals as
having a distinct ASD subtype, but clinical data are
limited.
Methods We report five autistic probands identified by
microarray analysis with copy number variation (CNV) of
16p11.2 (three deletions, two duplications). Each patient
was assessed for ASD and dysmorphic features. We
also describe a deletion positive 26-month-old female
who has developmental delay (DD) and autistic features.
Results Proband 1 (female with ASD, de novo deletion)
is not dysmorphic. Proband 2 (male with autism, de novo
deletion) and proband 3 and his brother (males with
autism, inherited deletions) are dysmorphic, but the two
probands do not resemble one another. The mother of
proband 3 has mild mental retardation (MR), minor
dysmorphism and meets the criteria for ASD. Proband 4
(dysmorphic autistic male, de novo duplication) had
a congenital diaphragmatic hernia. Proband 5 (non-
dysmorphic ASD female with a duplication) has two
apparently healthy duplication positive relatives.
Probands 1 and 2 have deletion negative siblings with
ASD and Asperger syndrome, respectively. Proband 6 (a
female with DD and an inherited duplication) is
dysmorphic, but has oligohydramnios sequence.
Conclusions The phenotypic spectrum associated with
CNV at 16p11.2 includes ASD, MR/DD and/or possibly
other primary psychiatric disorders. Compared with the
microduplications, the reciprocal microdeletions are more
likely to be penetrant and to be associated with non-
specific major or minor dysmorphism. There are deletion
positive ASD probands with a less severe phenotype
than deletion negative ASD siblings underscoring the
significant phenotypic heterogeneity.
INTRODUCTION
Autism (OMIM 209850), typically apparent by the
age of 3 years, is characterised by impaired commu-
nication, impaired reciprocal social interaction skills,
and by restricted repetitive behaviours and interests.
Autism spectrum disorder (ASD) is a broader pheno-
type, which includes autism as well as less severe
conditions such as Asperger syndrome and pervasive
developmental disorder-not otherwise specified
(PDD-NOS).1 The prevalence of autism is 3 per 1000
and rises to 6 per 1000 when all forms of ASD are
included.2 The male to female ratio isw4:1 and after
syndromic forms of ASD are excluded, it is associated
with an empiric sibling recurrence risk of 5e10%.3
The ASDs are aetiologically heterogeneous.
About 10% are associated with a Mendelian
syndrome (eg, fragile X syndrome and tuberous
sclerosis complex). Another 5e7% are associated
with a cytogenetically visible chromosome abnor-
mality, the most frequently observed being a mater-
nally derived duplication of 15q11-13.4 Teratogens,
including in utero exposure to rubella and valproate,
have also been implicated.5 The remainder of
affected individuals are presumed to have multifac-
torial forms of ASD and linkage scans have mapped
candidate risk loci.6 More recently, de novo copy
number variations (CNVs) have been observed in
7e10% of sporadic ASD patients and in 2e3% of
affected individuals from multiplex families.7 8
Three studies have recently discovered recurrent
microdeletions and microduplications at the
16p11.2 locus in ASD cohorts.8e10 This 555 kb
CNV region, which is flanked by segmental dupli-
cations having>99% sequence identity, is presumed
to have an elevated mutation rate due to its genomic
architecture.11 In our previous study, we identified
4/427 (w1%) unrelated Canadian ASD patients
who had chromosome 16p11.2 CNVs. The equiva-
lent change was not observed in 1652 controls.8
Weiss and colleagues made a similar observation in
12 of 751 (1.6%) families having two or more ASD
siblings (multiplex families) from the Autism
Genetic Resource Exchange (AGRE) repository.10
Moreover, they found dosage changes at 16p11.2 in
5/512 children (w1%) who had either develop-
mental delay (DD) or suspected ASD, in 3/299
(w1%) patients from an Icelandic ASD cohort, and
in 2/18 834 (0.01%) of Icelandic unscreened
controls. Kumar et al found 16p11.2 CNVs in 5/712
(0.7%) unrelated autism probands comprised of 410
AGRE cases and 302 probands from the National
Institutes of Mental Health Genetics Initiative
(total of 87 simplex cases and 635 multiplex cases).9
Four of the microdeletion patients reported byWeiss
et al overlapped with the Kumar study (see
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Supplementary table 1). Subsequent exon sequencing of eight
biological candidate genes within this locus failed to identify any
variants associated with ASD.12
Bijlsma et al13 have now reported that 14/4284 (0.33%) indi-
viduals referred for mental retardation and/or multiple congen-
ital anomalies carry the same 16p11.2 microdeletion. Only four
of the probands were formally assessed for autism, with one
receiving a diagnosis. Interestingly, three apparently normal
transmitting parents (two mothers, one father) were identified.
Here we present detailed genotypeephenotype correlation for six
probands with CNVat 16p11.2, emphasising detailed assessment
for ASD and dysmorphology in the index case and in the CNV/
ASD positive family members. Coupled with a literature review,
our findings reinforce the role of this 16p11.2 region in ASD, but
reveal many complexities in interpreting clinical outcomes.
METHODS
Human subjects
ASD cases were collected through a multicentre Canadian
research team using common ASD protocols approved by
respective research ethics boards of the institutions where clin-
ical evaluations were performed (the Provincial Medical Genetics
Program, St John’s Newfoundland; the Hospital for Sick Chil-
dren, Toronto; the Offord Center for Child Studies, Hamilton,
Ontario). Informed consent including consent to publish
photographs was obtained from each participant or legal
guardian. Probands 1e5met the criteria for ASD based on Autism
Diagnostic Interview-Revised,14 Autism Diagnostic Observation
Schedule (ADOS)15 and clinical history, with the exception of
proband 5 who had a Childhood Autism Rating Scale16 rather
than an ADOS. One of three medical geneticists (BF, RW, SM)
reviewed the medical charts and performed physical examina-
tions for dysmorphic features. Additional clinical evaluations
included speech assessments (Oral Written and Language Scales,
OWLs17) and Intelligence Quotient (IQ) testing. For the latter,
Leiter International Performance scale18 was used for those who
were young or significantly verbally impaired, and Wechsler
Intelligence Scale19 was used for those who were able to
complete the test.
Microarray analysis
DNA samples were genotyped using one or more of the Affy-
metrix 500K, Affymetrix 6.0, or Illumina 1M single nucleotide
polymorphism arrays according to standard protocols (see table
1).8 For all microarray platforms, multiple calling algorithms
were used to maximise CNV detection (sensitivity) and call
accuracy (specificity). For the Affymetrix 500K array, the analysis
tools dChip, CNAG, and GEMCA were used while Birdsuite,
Partek Genomics Suite, and Affymetrix GTC were used for the
analysis of the Affymetrix 6.0 arrays. For Illumina 1M arrays, the
programs Quanti-SNP, PennCNV, and iPattern (unpublished)
were employed for CNV detection. CNVs were merged if they
were detected in the same individual by more than one algorithm
using the outside probe boundaries. We have observed that those
CNVs detected by more than one analysis tool validate at a rate
of >95% using quantitative polymerase chain reaction (PCR)
assays. All 16p11.2 CNVs were detected by all relevant algo-
rithms. We used identical methods to examine 2387 population
controls (but not assessed for autism) and found none with CNV
of this region8 20; nor was the region identified as variable in the
Database of Genomic Variants.21
For CNV validation, two independent SYBR Green based
quantitative assays were used (primer sequences available upon
request) to measure relative copy number in cases and controls
between 16p11.2 and a control region (FOXP2). Standard fluo-
rescent in situ hybridisation (FISH) techniques were also used for
validation with RP11-114A14 (at 16p11.2) used as a test probe
and RP11-553M22 (at 16q22.1) used as a control probe.
RESULTS
Table 1 and figures 1 and 2 summarise our original findings and
table 2 integrates these results with the literature. Our results
focus on genotype and phenotype correlations for 16p11.2 CNVs
in ASD families. We also examined parents for potential inver-
sions that might predispose to CNV events in children,22 but in
those tested no inversion was detected (figure 2h,i).
Proband 1
This 18-year-old female has ASD and a de novo 16p11.2
microdeletion. While microarray analysis did not identify
mosaicism, subsequent FISH testing showed 50% mosaicism for
the deletion (figure 2eeg). Although not examined by a medical
geneticist, no dysmorphic features were recorded in her medical
chart. At 5 years, her head circumference was 51 cm (50th
centile). Her younger brother was diagnosed with ASD at
10 years, but is microdeletion negative.
Proband 2
This 13-year-old male has autism and a de novo microdeletion.
He was born to a 26-year-old G2P1 mother and a 29-year-old
father. Pregnancy and delivery at termwere uncomplicated. Birth
weight was 2665 g (2nde9th centile). At 14 months, eye contact
deteriorated and he lost a four word vocabulary. By 4 years, he
was obese. He was prescribed sertraline for anxiety at 7 years.
At 13 years (figure 3a,b), height was 157 cm (25th centile),
weight was 104.75 kg (>97th centile), and head circumference
was 59 cm (+3SDs). He had a low nuchal hairline, a short neck
and a strikingly flat facial profile with low set ears. Palpebral
fissures were narrow and long. Nose was short, with a flat broad
nasal root/bridge and a delicate tip. Philtrum was smooth and
mouth was downturned. Upper incisors were widely spaced and
chin was pointed. Hand length was 17.2 cm (3rde25th centile)
with distally tapered fingers. Toes were short with 2/3 cutaneous
syndactyly (extending half way up the interdigital space). Finger
and toenails were thin and deep set. He had micropenis with
testicles that were starting to enlarge.
His 15-year-old sister was diagnosed with Asperger syndrome
at 12 years, but is microdeletion negative. She is not dysmorphic.
Proband 3
This 5-year-old male has autism and a microdeletion inherited
from his mother who has mild mental retardation (MR) and
ASD. He was born to a 29-year-old G1P0 mother and a 28-year-
old father. Pregnancy was uncomplicated until mother was
admitted with an antepartum bleed. He was born at 28+3 weeks
and was extubated within the first 24 h of life. At 6 weeks, he
was discharged from the neonatal intensive care unit (NICU)
into foster care. At 14 months, extremities were hypertonic and
he was diagnosed with spastic cerebral palsy. He walked at
27 months. At 5 years he had no speech, but had learned a few
signs.
At 4.5 years, height was 99.5 cm (25th centile), weight was
16.5 kg (50th centile) and head circumference was 51.3 cm (50th
centile). He had a frontal cowlick with a double hair whorl. He
had a tall broad forehead with hypertelorism (inner canthal
distance 3.4 cm, >+2SD). Midface was hypoplastic and nares
were anteverted. Philtrum was smooth and measured 1.2 cm
(3rde25th centile). His mouth was wide and ears were
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posteriorly rotated. He had fifth finger clinodactyly and a small
umbilical hernia.
His autistic brother also carries the 16p11.2 microdeletion (see
below).
Patient 3b (brother of proband 3)
This 4-year-old deletion positive boy also has autism. He is the
second and only other child of the parents. Mother had threat-
ened labour from 24 weeks and he was born vaginally at
36 weeks. Birth weight was 2800 g (50the75th centile), head
circumference was 32.5 cm (50th centile) and birth length was
46.5 cm (25the50th centile). He was discharged at 3 days into
foster care. At 7 months, he had a urinary tract infection and
three febrile seizures. He was treated with phenobarbital until
16 months. He crawled at 18 months and walked at 21 months.
At 3.5 years, height was 105 cm (90th centile), weight was
16.1 kg (50the75th centile) and head circumference was 50.4 cm
(50th centile). He also had a tall broad forehead and resembled his
brother. Midface was hypoplastic with a smooth philtrum that
measured 0.9 cm (3rde25th centile). He had a cupid bow contour of
the upper lip, and an everted lower lip. He had low set, posteriorly
rotated asymmetric ears and a right helical pit. Distal fingers were
broad, fourth toes were curved, and he had a small umbilical hernia.
Patient 3c (mother of proband 3)
This 35.5-year-old woman was also deletion positive. She
required special education and reads at a grade 3 level. She was
diagnosed with depression at 12 years with multiple subsequent
episodes. At 35, full scale IQ (Wechsler Adult Intelligence Scale)19
was 56 (0.2 centile). Listening comprehension, OWLs17 was at
a 13.5 year level. Once her microdeletion was identified, she was
assessed for autism, and clinical history and ADOS-4 assessment
led to a diagnosis of ASD (communication+social interaction
total score¼10, ASD cutoff¼7).
When examined at 35.5 years (figure 3c,d), height was 157 cm
(10the25th centile), weight was 85.6 kg (>95th centile) and
head circumference was 54.4 cm (50th centile). She was
brachycephalic with a receding hairline. She had deep-set eyes
with minor dysmorphism including a smooth philtrum (length
1.5 cm, 25the50th centile), large ears (length 6.9 cm, >+2SD)
and unusually short 5th toes. She had an unexplained long-
standing intention tremor.
Proband 4
This 15.5-year-old male has autism (simplex case) and a de novo
16p11.2 microduplication. He had a repaired congenital dia-
phragmatic hernia (CDH). His other medical problems included
epilepsy, an anxiety disorder with good response to fluvoxamine,
and scoliosis. He has two other rare CNV gains (654 kb and
479 kb both mapping to 10q11.21) not seen in controls. None of
the congenital diaphragmatic hernia loci map to either of these
CNVs. When examined at 15.5 years of age, height was 155 cm
(<5th centile), weight was 38.1 kg (<5th centile) and head
circumference was 54.5 cm (50th centile). He had hypertelorism
with a smooth philtrum. Ears were small with curved pinnae. He
had long slender fingers and toes. Hand length was 15.8 cm and
foot length was 22.3 cm (both <3rd centile).
Proband 5
This 13-year-old girl has ASD and an inherited microduplication,
which is also present in her healthy mother and sister. She was
born to a 30-year-old G1P0 mother and a 32-year-old father.
Delivery was induced for polyhydramnios at 38 weeks, and there
were no neonatal complications. Birth weight was 3505 g
(75the90th centile), length 52 cm (90th centile) and head
circumference 35.5 cm (90th centile). When examined at 13 years
(figure 3e,f), eye contact was inconsistent. Height was 145.5 cm
(5th centile) with an arm span of 144 cm. Weight was 29.3 kg
Table 2 Summary of autistic probands with recurrent CNV at 16p11.2, and of the phenotypes and deletion or duplication status of their first degree
relatives (this report as well as7e10 13)
ASD
subtype
(proband
or
relatives)
Autistic probands with
16p11.2 CNV,
sex of proband
(origin of deletion
or duplication)
Autistic first degree
relatives concordant for
ASD subtype compared
with proband (relative’s
deletion or duplication
status, proband’s sex)
Autistic first degree
relatives discordant for
ASD subtype compared
with proband (relative’s
deletion or duplication
status, proband’s sex/
proband’s ASD subtype)
Non-autistic first degree
relatives with deletion
(relative’s phenotype,
proband’s sex/proband’s
ASD subtype)
Non-autistic first degree
relatives with duplication
(relative’s phenotype,
proband’s sex/proband’s
ASD subtype)
Autism Proband 3, M (mat del)
Proband 2, M (de novo del)
1M (del, gonadal mosaicism)
1M (de novo del)
1M (de novo del)
1M (de novo del)
1F (del, unk)
1M (pat del)
Proband 4, M (de novo dup)
1M (mat dup)
1M (pat dup)
1M (de novo dup)
1F (mat dup)
Proband 3’s brother (del-pos,
proband M)
1 sister (del-pos, proband M)
1 brother (del-neg, proband M)
1 brother (del-neg, proband M)
1 brother (del-neg, proband M)
3 brothers (dup-pos, proband M)
1 brother (dup-neg, proband M)
None 1 father (speech delay,
proband M/autism)
1 brother (speech disorder
/MR, proband M/autism)
1 sister (normal, proband
M/autism)
1 mother (depression/anxiety/
learning disability, proband
F/autism)
ASD Proband 1, F (de novo mosaic
del)
1M (pat del)
Proband 5, F (mat dup)
Proband 1’s brother (del-neg,
proband F)
Proband 3’s mother (del-pos,
proband M/autism)
1 sister (dup-pos, proband
M/autism)
1 father (ADHD, proband
M/ASD)
Proband 5’s sister (normal,
female
proband/ASD)
Proband 5’s mother (normal,
female
proband/ASD)
Asperger
syndrome
1F (de novo del)
1F (de novo del)
None Proband 2’s sister (del-neg,
proband M/autism)
None None
Total 18 10 3 3 4
Italicised font, probands and relatives from this report, regular font, previously reported probands and relatives.
ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; MR, mental retardation; M, male; F, female; del, deletion; dup, duplication; pat, paternal; mat, maternal; unk, origin
of CNV unknown; del-pos, deletion positive; del-neg, deletion negative; dup-pos, duplication positive; dup-neg, duplication negative.
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(<5th centile) and head circumference was 52 cm (50th centile).
Upper to lower segment ratio was reduced (0.875). She was not
dysmorphic, although mild synophrys and a smooth philtrum
(a feature seen in her mother) were noted.
Her duplication positivemother is a 44-year-old homemaker with
a grade 9 education (figure 3g). Her 8-year-old sister (figure 3f), who
also caries the duplication is healthy with no social or academic
difficulties (negative Autism ScreeningQuestionnaire23). Apart from
a smooth philtrum in the mother, neither had dysmorphic features.
Proband 6
This 26-month-old girl has mild developmental delays and
a microduplication inherited from her father who left vocational
school in grade 11 and who was recently diagnosed with bipolar
disorder. The proband was born to a 24-year-old G4P2A1 mother
and a 29-year old father. Pregnancy was complicated by severe
oligohydramnios, and maternal smoking and cannabis use. She
was delivered vaginally at 38 weeks with a birth weight of 1145 g
(50the75th centile). Hypotonia and evidence of oligohy-
dramnios sequence (Potters facies, left talipes varus) were noted
at birth. She was ventilated for 3 weeks and discharged from
hospital at age 78 days. She sat at 14 months, walked at
21 months and first spoke at 16 months. At 21 months, Bayley
Infant Scale of Mental Development24 showed low-average
cognitive skills, borderline-low motor skills and low-average
language skills. Her hypotonia improved although she uses
orthotics for walking.
When examined at 26 months, eye contact was inconsistent
and play was mainly solitary. A formal assessment for autism is
pending. Height was 82 cm (3rd centile), weight was 11.3 kg
(25th centile) and head circumference was 46.5 cm (10th centile).
She had distinctive facial features including frontal bossing with
notably receding hairline, hypoplastic supraorbital ridges, sparse
eyebrows and eyelashes, deep-set eyes, smooth philtrum, thin
upper lip and a flat facial profile (figure 3h). She had single palmar
creases and fifth finger clinodactyly (figure 3i).
DISCUSSION
Our collective analyses reveal extensive phenotypic heteroge-
neity in individuals with ASD and their relatives carrying
microdeletion or microduplication of chromosome 16p11.2. In
this case series and in several previous studies reporting indi-
viduals with CNVat 16p11.2, patients were ascertained because
of a diagnosis of ASD7 9 10 so that autistic individuals may be
overrepresented in the literature to date. Nevertheless, a signifi-
cant trend in the data is that 16p11.2 microdeletions are more
penetrant with respect to ASD and dysmorphic features
compared with the reciprocal microduplications.
Excluding probands 1 and 2 from this study (first published by
Marshall et al in 20088), 40 microdeletion patients from 27
families have been reported7 9 10 13 25 (supplementary table 1).
The breakdown of diagnoses is as follows: 10 patients had an
ASD (table 2), four had DD with autistic features, 17 had DD/
MR without autistic features, three had speech disorders
without MR, and two had attention deficit hyperactivity
disorder (ADHD). One deletion positive female, who was
developmentally normal at 3.5 years, had an array because of
dysmorphic features and Wilms tumour (proband 25, supple-
mentary table 1). This girl’s deletion positive father and two
deletion positive mothers of females with MR were normal, but
psychometric testing was not performed.13 Twenty-four of 27
microdeletion probands had parental testing and the origin was
de novo in 16 and inherited in eight.
For 10 previously reported microdeletion patients with
ASD7 9 10 13 (supplementary table 1), the lowest reported non-
verbal IQ was 73 and two patients had Asperger syndrome. The
three deletion patients characterised in this study had ASDs of
variable severity (table 1). Probands 1 (ASD) and 2 (autism) are
higher functioning while proband 3 and his deletion positive
brother (both autism) are non-verbal, compared with a less severe
form of ASD in their deletion positive mother. She has mild MR
and was only diagnosed with ASD at age 35, after her micro-
deletion was identified.
Dysmorphology was assessed in 22 of 40 previously reported
deletion cases.10 13 25 The male MZ twins reported by Ghebra-
nious had dysmorphism that was present in a deletion-negative
sibling (supplementary table 1).25 Of the remaining 20 patients,
nine were dysmorphic with no common appearance. Our data
suggest that the deletion can be associated with variable
dysmorphism. Proband 2 has very dysmorphic facial features,
digit abnormalities, micropenis and a hemivertebra. Proband 3
and his deletion positive brother share the same dysmorphic facial
features, but do not resemble proband 2. The brothers’ deletion
positive mother has less striking dysmorphism than her sons.
Figure 1 Pedigrees of families with
16p11.2 copy number variants. Black
symbols indicate a diagnosis of autism
spectrum disorder (ASD) or autism, the
grey symbol indicates Asperger
syndrome, the symbol with hatched
diagonal lines indicates developmental
delay (DD), and the symbol with hatched
vertical lines indicates bipolar disorder.
Additional clinical details are provided in
table 1. The proband is denoted by an
arrow. The deletion in the MM0088
proband was determined to be mosaic
(50:50) by fluorescent in situ
hybridisation (FISH) analyses.
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We conclude that autistic individuals with microdeletion
16p11.2 often have a more complex phenotype than those with
presumed multifactorial forms of ASD. They are more likely to
have additional medical findings including congenital anomalies,
dysmorphism, growth disturbance, motor delay and epilepsy.
Within ASD research cohorts, there is a need to collect this type
of data systematically.
Probands 1 and 2 (deletion positive) both have ASD siblings
who are deletion negative (table 1). Four previously reported
patients with deletion or duplication negative autistic sibs are
summarised in supplementary table 2 (all pairs of brothers).10 12
In three of the four sib pairs, the deletion positive male had
a less severe phenotype than his deletion negative brother.
We add the first two sib pairs who are discordant for the
16p11.2 CNV and gender. Proband 1 (deletion positive female)
and her deletion negative brother both have ASD. They
have comparable IQs and language abilities, but she is higher
functioning, with higher Vineland Adaptive Behavioural
Scale scores.26 Proband 2 (deletion positive male) has autism
and his deletion negative sister has Asperger syndrome. In
both families, the females were less impaired than the males,
suggesting that the sex difference that protects females against
the development of ASD may also give them a relative advan-
tage even when a rare CNV acts.27 These six families demon-
strate that even within multiplex families, there is genetic
heterogeneity.
Table 2 summarises 18 ASD probands (including five from
this report) with CNVat 16p11.2.7e10 13 Viewed in this way, the
data also support the concept of female gender as protective
against ASD. These 18 patients collectively had 10 autistic first
degree relatives concordant for ASD subtype (only three were
positive for the proband’s CNV), and three autistic first degree
relatives discordant for ASD subtype. Nine of 10 of the concor-
dant relatives were males (usually of a male proband) and all
three discordant relatives were females with a milder ASD than
the male proband.
Figure 2 (aeg) Fluorescent in situ hybridisation (FISH) testing for 16p11.2 microdeletion or duplication using differentially labelled bacterial artificial
chromosome (BAC) clones RP11-114A14 (16p11.2, test probe, SpectrumOrange) and RP11-553M22 (16q22.1, control probe, SpectrumGreen). (a and b)
Metaphase chromosomes and interphase nuclei from proband 5 (NA0133-000) showing one normal and one enhanced signal. (c and d) Metaphase
chromosomes and interphase nuclei from an individual with microdeletion 16p11.2 (AGRE proband AU0938301) showing a single red signal. (e and f)
Metaphase chromosomes from proband 1 (MM0088-003) who had a 50% mosaic microdeletion; 8/15 cells showed a red signal on both homologues (e)
and 7/15 cells showed loss of test signal on one homologue (f). (g) Interphase nuclei from proband 1 (MM0088-003) showing a deletion signal pattern in
2/4 cells; 100 nuclei were scored and 48/100 showed a single test probe. (h and i) Inversion testing for SK0102-002 using three colour interphase FISH.
He is the father of proband 4 (SK0102-004 who has a de novo duplication). The three probes are fosmids G248P82830F11 (SpectrumGreen),
G248P87322G6 (Spectrum Orange) and G248P8542C4 (anchor, Biotin detected with Avidin-Cy5). Both cells show a normal probe order. Both parents
were examined in eight families (MM0088, SK0102, SK0019 see figure 1; and AGRE families AU0419, AU0298, AU0029, AU0154, AU0938 see
Supplementary table 1). In one exception, the 16p11.2 duplication positive mother from family AU0029 was not tested. Two hundred interphase nuclei
were scored for each parent.
200 J Med Genet 2010;47:195e203. doi:10.1136/jmg.2009.069369
Letter to JMG
 group.bmj.com on October 4, 2010 - Published by jmg.bmj.comDownloaded from 
Excluding probands 4 and 5 first described by Marshall et al,8
15microduplication patients have been reported from 10 families9
10 28 (supplementary table 3). Eight had ASD (table 2), one had
motor delay with autistic features, three had DDwithout autistic
features, two had childhood onset schizophrenia, and one had
psychiatric problems. IQs for seven patients ranged from 50e110.
Probands 4 (autism) and 5 (ASD) have borderline and mild MR,
respectively. Proband 6 is 26 months old and has developmental
lags, with abnormal eye contact and play skills. She is relatively
young and a formal assessment for autism is pending.
Four of 15 previously reported duplication patients were
examined for dysmorphic features and none were identified10
(supplementary table 3). Proband 4’s dysmorphism and dia-
phragmatic hernia may be related to the other rare CNVs iden-
tified. Proband 6 is also dysmorphic, but at least some of her
features are related to in utero compression. Proband 5 and her
duplication positive mother and sister were not dysmorphic.
The origin of the duplication was determined for six of 10
previously reported probands. One was de novo and five were
inherited (supplementary table 3). Two of the three duplication
patients from this report (probands 5 and 6) had inherited
duplications. Proband 5’s mother and sister are both duplication
positive with no overt health problems apart from academic
challenges in the mother. This suggests that like micro-
duplications of 22q11.2, 16p11.2 duplications can be associated
with a normal phenotype.29 Genotype driven studies of general
populations30 or phenotype driven studies of non-ASD/MR
phenotypes might yield more 16p11.2 duplications, with many
being inherited because of less selective pressure.
In fact, 16p11.2 dosage changes may confer susceptibility to
other psychiatric disorders including ADHD. Of 40 previously
reported deletion patients (supplementary table 1), seven had
aggression, over activity or ADHD.9 10 Of 15 previously reported
duplication patients (supplementary table 3), two had childhood
onset schizophrenia28 (which shares many features with ASD)
and one had anxiety and depression.9 Weiss et al10 screened other
psychiatric cohorts and found the deletion in 1 of 648 patients
with schizophrenia, 1 of 420 patients with bipolar disorder, and 1
of 203 patients with ADHD. In our data, probands 2 and 4 had
anxiety disorders, proband 3 had hyperactivity, proband 3’s
deletion positive mother had childhood onset depression, and
proband 6’s duplication positive father had bipolar disorder.
Our data reconfirm our earlier recommendation8 and that of
others31 to include chromosomal microarray in the assessment of
autistic individuals. However, given the complexities of the
genotypeephenotype correlations observed, we emphasise the
importance of considering as much family information as possible
when assessing the impact of the CNV on outcomes.27 As one
example, by age 3 years, proband 3was diagnosedwith autism and
cerebral palsy. If his mother had sought recurrence risk counselling
at this stage, a microarray would not have been routinely ordered
in our institution. A specific diagnosis would not have been made
and the phenotypes of mother and son (minor dysmorphism with
MR and major dysmorphism with autism) may not have been
recognised as manifestations of the same genetic disorder. With
microarray results now available, proband 3’s deletion positive
mother has been counselled that each future child is at 50% risk of
inheriting her deletion and that a deletion positive child is at risk
for medical problems including, but not limited to, ASD.
As a second example, proband 1 carried a mosaic micro-
deletion, which likely contributed to her ASD. Nevertheless, her
parents then had another more severely affected deletion nega-
tive son. We suggest that this couple’s future recurrence risk is
lower than the 25e35% empiric risk figure given to parents who
have two children with apparently multifactorial ASD, but
cannot more precisely quantify this.32 33
Glessner et al34 recently published a CNV study in which 1995
ASD cases and 2519 controls were screened using the Illumina
HumanHap550 Beadchip. The frequency of 16p11.2 CNVs was
reported to be similar in the cases and controls (seven deletions in
ASD probands vs four in controls; five duplications in ASD
probands vs four in controls). The authors screened two ASD
cohorts: a discovery cohort of 859 children recruited from
multiple US centres, and an AGRE cohort of 1336 cases. The four
Figure 3 Clinical photographs. (a and b) Proband 2 (de novo deletion 16p11.2). Note long narrow palpebral fissures, short delicate nose, short neck and
brachydactyly with 2e3 cutaneous toe syndactyly. (c and d) Mother of proband 3 (both with deletions). Note her large ears, smooth philtrum and short
fifth toes. (e) Proband 5 who has a maternally inherited duplication. (f) Proband 5 (note smooth philtrum) and her healthy duplication positive sister. (g)
Duplication positive mother of proband 5, who also has a smooth philtrum. (h) Proband 6 (inherited duplication and oliogohydramnios sequence). Note
her frontal bossing, receding hairline, hypoplastic supraorbital ridges and smooth philtrum. (i) Proband 6’s right hand showing fifth finger clinodactyly.
Written consent to publish these images has been obtained from each patient or legal guardian.
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deletions and three duplications identified in the AGRE ASD
probands have been reported previously.9 10 (supplementary
tables 1 and 3). The three unique deletions and the two unique
duplications in the discovery cohort are summarised in supple-
mentary table 4.
The controls in this study were reportedly recruited through
primary care clinics and ranged in age from 1e19 years. Each
child’s history was negative for ASD, DD and chronic disease as
determined by questionnaires and review of the electronic
medical record. It is possible that at least some of the eight control
CNVs were identified in young children (<age 2 years) when
ASD and the other phenotypes discussed above may not be
apparent. As evidenced by proband 3’s mother, higher functioning
forms of ASD may not be diagnosed until adulthood. Also, the
authors did not specify that the control group excluded siblings of
the ASD cases. Finally, they reported CNV regions (CNVRs) and
several cases and controls appear to have had very small CNVs
that are not typical full length deletions or duplications.34
We failed to identify any 16p11.2 CNVs in 2387 population
controls, perhaps because these individuals were older. Our
controls included German adult blood donors and Canadians >age
60 years who were part of a coronary artery disease study. Our
negative control results are in keeping with the identification of
two deletions in 18834 unscreened Icelandic population controls.10
The five deletion positive individuals in our case series all had
abnormal phenotypes which we believe are at least partially
attributable to the CNV; however, the seven apparently healthy
deletion positive individuals reported by Glessner et al and
Bijlsma et al13 34 suggest that 16p11.2 deletions (like the dupli-
cations) may be incompletely penetrant. Further studies are
needed including formal psychometric assessments of apparently
healthy individuals with 16p11.2 microdeletions.
Genetic counselling for parents at risk of having a child with
a 16p11.2 CNV is challenging. The phenotypic spectrum
includes ASD, MR/DD and/or possibly other primary psychi-
atric disorders, but a normal outcome is also possible. The latter
appears more likely for duplications than for deletions. Deletions
can also be associated with non-specific major or minor
dysmorphism. Additional case reports as well as prospective
cohort analyses of patients with ASD and other disorders will
allow these interpretations to be refined.
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